510(k) Report

510(k) · Cleared

Cleared

REMI AI Discrete Detection Module

K231779510(k) TraditionalCleared Jan 3, 2024201-day reviewClass II21 CFR 882.1400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Epitel, Inc. · OMB Automatic Event Detection Software For Full-Montage Electroencephalograph

Cleared on Jan 3, 2024 as substantially equivalent to K182181 (Persyst Development Corporation, 2018) after a 201-day review. Its family tree reaches back 1 generation to 2018. 1 later device descends from it.

Decided
Jan 3, 2024
Review
201 days
Class
Class II
Product code
OMB
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K182181 (2018). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2024: 1 descendant clearedK182181 · Persyst 14 EEG Review and Analysis Software · Persyst Development Corporation · 2018201620182020202220242026
Descendants, by generation 1 generation forward: 1 descendant K182181 · Persyst 14 EEG Review and Analysis Software · Persyst Development Corporation · 20180
  1. Root · 1 generation backK182181 Persyst 14 EEG Review and Analysis SoftwarePersyst Development Corporation · 2018
  2. This deviceK231779 REMI AI Discrete Detection ModuleEpitel, Inc. · 2024
  3. Descendant · cites it directly · 0 of its ownK240408 REMI-AI Rapid Detection Module (REMI-AI RDM)Epitel, Inc. · 2024

Most influential descendants

Showing 1 of 1 · See all
  • K240408REMI-AI Rapid Detection Module (REMI-AI RDM)Epitel, Inc. · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K182181Persyst 14 EEG Review and Analysis SoftwarePersyst Development Corporation2018—
0 (this device)K231779REMI AI Discrete Detection ModuleEpitel, Inc.2024—
+1K240408REMI-AI Rapid Detection Module (REMI-AI RDM)Epitel, Inc.2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
FIG. 1 — Lineage of K231779, 2018–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OMB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OMB device

  1. #1 K240993 encevis (2.1)score 15.0 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K182181Persyst 14 EEG Review and Analysis Software
Summary page 5
…Product Code and Regulation Number: OMB - Sec. 882.1400 3. Predicate Device Name of Device: Persyst 14 EEG Review and Analysis Software 510(k) Number: K182181 Manufacturer: Persyst Development Corporation 4. Device Description REMI-AI Discrete Detection Module (REMI-AI DDM) is a…
Persyst Development Corporation2018—

Also cleared against K182181: 3 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K240408REMI-AI Rapid Detection Module (REMI-AI RDM)Epitel, Inc.20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K240408 (Epitel, Inc., 2024) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K182181.

How does its category compare?

All OMB devices

OMB Automatic Event Detection Software For Full-Montage Electroencephalograph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · OMB

5in 2025

2009: 12010: 12012: 12013: 12014: 22015: 32017: 12018: 32019: 12020: 12021: 12022: 12023: 22024: 52025: 52026 (partial year): 1
2007high 5 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OMB

143in 2025

2015: 233 days median2018: 108 days median2024: 201 days median2025: 143 days median
2007high 233 (2015) · low 108 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OMB

1in 2021

2021: 1
2007high 1 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OMB

6in 2025

2011: 12014: 22022: 12023: 42024: 212025: 6
2007high 21 (2024) · low 0 (2007)2025

MAUDE reports naming product code OMB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20101—00
20110—01
20121—00
20131—00
20142—02
2015323300
20160—00
20171—00
2018310800
20191—00
20201—00
20211—10
20221—01
20232—04
20245201021
2025514306
20261—0—

What is it indicated for?

The REMI-AI Discrete Detection Module (REMI-AI DDM) is indicated for the analysis of REMI Remote EEG Monitoring System electroencephalogram (EEG) recordings. REMI-AI DDM is intended to be used by physicians qualified to analyze and interpret EEG who will exercise professional judgment in using the information. As an aide to the qualified physician’s REMI EEG review, REMI-AI DDM marks previously acquired sections of REMI EEG that may correspond to…

Read the full statement (122 words)

The REMI-AI Discrete Detection Module (REMI-AI DDM) is indicated for the analysis of REMI Remote EEG Monitoring System electroencephalogram (EEG) recordings. REMI-AI DDM is intended to be used by physicians qualified to analyze and interpret EEG who will exercise professional judgment in using the information.

As an aide to the qualified physician’s REMI EEG review, REMI-AI DDM marks previously acquired sections of REMI EEG that may correspond to neurological events of interest indicative of potential electrographic seizures lasting at least 10 seconds in duration. REMI-AI DDM is indicated for use with adult and pediatric patients (6+ years).

REMI-AI DDM does not mark REMI EEG records in real time and does not provide any diagnostic conclusion about the patient's condition to the user.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K231779: REMI AI Discrete Detection Module.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K231779

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026